Gregory Cote

Hematology | Oncology
55 Fruit St Ste 7B
Boston, MA 02114

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 89 publications

Global Consensus on the Management of Primary Localized Chordoma.

Global Consensus on the Management of Primary Localized Chordoma.

Journal: JAMA oncology
Published: July 09, 2026

Multimodality Cardiovascular Imaging Reveals Late Recurrence of Cardiac Neoplasm.

Multimodality Cardiovascular Imaging Reveals Late Recurrence of Cardiac Neoplasm.

Journal: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Published: May 18, 2026

Multimodality cardiovascular imaging reveals late recurrence of cardiac neoplasm.

Multimodality cardiovascular imaging reveals late recurrence of cardiac neoplasm.

Journal: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Published: May 18, 2026

A pooled analysis of phase 2 clinical trials in advanced chordoma.

A pooled analysis of phase 2 clinical trials in advanced chordoma.

Journal: European journal of cancer (Oxford, England : 1990)
Published: May 07, 2026

Pooled safety analysis of lurbinectedin plus irinotecan in patients with advanced solid tumors.

Pooled safety analysis of lurbinectedin plus irinotecan in patients with advanced solid tumors.

Journal: Investigational new drugs
Published: March 12, 2026

Clinicopathologic evaluation of dedifferentiated liposarcoma lacking MDM2 amplification.

Clinicopathologic evaluation of dedifferentiated liposarcoma lacking MDM2 amplification.

Journal: Histopathology
Published: January 06, 2026

Prospective, Randomized Dose Escalation Trial with Proton-Based Radiation for Skull Base and Cervical Spine Chondrosarcomas: 30-year outcomes from PROG 85-26.

Prospective, Randomized Dose Escalation Trial with Proton-Based Radiation for Skull Base and Cervical Spine Chondrosarcomas: 30-year outcomes from PROG 85-26.

Journal: Neuro-oncology
Published: December 04, 2025

Prospective, randomized dose-escalation trial with proton-based radiation for skull base and cervical spine chondrosarcomas: 30-year outcomes from PROG 85-26.

Prospective, randomized dose-escalation trial with proton-based radiation for skull base and cervical spine chondrosarcomas: 30-year outcomes from PROG 85-26.

Journal: Neuro-oncology
Published: December 04, 2025

A Phase 2 Study of Eribulin in Patients with Metastatic Angiosarcoma and Epithelioid Hemangioendothelioma.

A Phase 2 Study of Eribulin in Patients with Metastatic Angiosarcoma and Epithelioid Hemangioendothelioma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 04, 2025

Combination of Lurbinectedin Plus Irinotecan: Preclinical and Early Clinical Results in Patients With Relapsed SCLC.

Combination of Lurbinectedin Plus Irinotecan: Preclinical and Early Clinical Results in Patients With Relapsed SCLC.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: June 25, 2025

Camonsertib, an ATRi, in Combination with Low-Dose Gemcitabine in Solid Tumors with DNA Damage Response Aberrations: Preclinical and Phase Ib Results.

Camonsertib, an ATRi, in Combination with Low-Dose Gemcitabine in Solid Tumors with DNA Damage Response Aberrations: Preclinical and Phase Ib Results.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 23, 2025

Phase I results on the efficacy, safety and pharmacokinetics of lurbinectedin and irinotecan in advanced solid tumors.

Phase I results on the efficacy, safety and pharmacokinetics of lurbinectedin and irinotecan in advanced solid tumors.

Journal: Investigational new drugs
Published: May 29, 2025
Showing 1-12 of 89

Last Updated: 09/26/2026